Press Releases and Statements
(WASHINGTON, D.C.) – The Consumer Healthcare Products Association (CHPA) today announced the appointment of M. Scott Furness, Ph.D., to serve as its new Senior Vice President of Regulatory & Scientific Affairs. Dr. Furness comes to CHPA from the U.S. Food and Drug Administration (FDA) where he spent more than 25 years in various leadership roles, most recently as Director of the Division of Product Quality Assessment XVIII at the Center for Drug Evaluation and Research’s (CDER) Office of Pharmaceutical Quality (OPQ), overseeing the scientific review and quality evaluation of the active pharmaceutical ingredient (API) section of regulatory applications and providing strategic guidance on pharmaceutical quality issues. Dr. Furness takes the role previously held by Mike Bailey and officially began his work at CHPA on May 6, 2025. He will serve as a member of CHPA’s Senior Management Team and report to President and CEO Scott Melville.
